Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Issued (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 2 years of Shares Issued data on record, last reported at -$133000.0 in Q4 2022.

  • For Q4 2022, Shares Issued fell 193.66% year-over-year to -$133000.0; the TTM value through Dec 2022 reached $230000.0, down 84.3%, while the annual FY2025 figure was $58000.0, 78.28% down from the prior year.
  • Shares Issued reached -$133000.0 in Q4 2022 per AVIR's latest filing, down from $140000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $795000.0 in Q3 2021 and bottomed at -$133000.0 in Q4 2022.